- Joined
- May 7, 2014
- Messages
- 1,760
- Reaction score
- 3,780
medgator said:Still nowhere close to what needs to happen to successfully compete with a competent PP
"To fill these slots, we will reduce and, in some cases, eliminate medical acceptance criteria. We will commit to see local patients within 48 hours and consultations from our colleagues within 48 hours."
Still nowhere close to what needs to happen to successfully compete with a competent PP
Yep. 48 hours? Maybe if I'm out of town for 47 of those 48.
I give patients my personal cell phone number and I answer their calls day or night - I will drop anything to answer their call. Once I recall I was on a cruise with one bar on my cell phone reception when I answered such a call on a patient. I am loathe to send patients to the ED and if I do, you better be damn sure either I will show up there myself or communicate everything relevant to the EM physician.
Extremely interesting article, thank you for posting it. Given the size/strength of MDACC, I have little doubt they will pull out of this in the long-term. But it looks like there will a lot of pain on the clinical faculty/staff side between now and then. I have to wonder why MD Anderson even has a residency program if those some physicians can't be trusted to do whole breast radiation in the community. Maybe building a proton center wasn't such a great idea financially . . .
Agree. I recently had a very young GBM patient (in her 20s) who had a GTR with very favorable genetics (positive for MGMT hypermethylation + IDH2 mutation). I felt it appropriate for her to get a second opinion at the local academic center where I sent her. She also tried to get a third opinion @ Mayo Rochester.
Eventually, I had to put my foot down and tell her that the benefit of post-op XRT is going to be compromised if she kept delaying treatment start. She opted to stay with us because we did everything efficiently.
Another problem I've noticed with people who get care in academic centers is when they call back with major problems after treatment. They are invariably told, "go to the ED." Easy to say when your doctor (and medical records!!) are hundreds of miles away. I give patients my personal cell phone number and I answer their calls day or night - I will drop anything to answer their call. Once I recall I was on a cruise with one bar on my cell phone reception when I answered such a call on a patient. I am loathe to send patients to the ED and if I do, you better be damn sure either I will show up there myself or communicate everything relevant to the EM physician.
Note that this level of care actually drives down medical costs by reducing unnecessary hospital stays and duplicate labs/imaging. If the purpose of Medicare reforms is truly to bend the cost curve, that ain't gonna happen with academic medical institutions running the show.
Glad they found a solution to that multi million $ deficit: "turning holiday parties into potluck events."
Sent from my iPhone using SDN mobile
Once I recall I was on a cruise with one bar
I've noticed the same a well. I think it's the research focus and not a lot of clinical volume compared with other programs.The graduating MDACC residents I've met have had less clinical knowledge than the average graduating radonc resident out there. Too much emphasis on research?
All MDA attendings have fallen in line with the company now, not just Buchholz. Every one of my patients is told erroneously that I "won't be able to spare your heart" or I'm "just a general radonc so won't be able to treat their sarcoma the way they could." It's absolutely infuriating that these academic attendings come up with all these bull**** hoops for us to jump through to be board certified, being ACRO accredited, etc, but then throw us all under the bus at every opportunity. Don't even get me started on the Alliance of Dedicated Cancer Centers (ADCC, http://www.adcc.org/). They take completely worthless SEER data with no cofounding variables whatsoever, then claim their survival is higher than the rest of us, even though in my experience only the wealthy and aggressively interested in care have the resources available to bother to travel to these places for treatment. They also erroneously claim their care is cheaper than the rest of us, which is so wrong it's laughable.I feel that the expertise of the faculty and staff in delivering whole breast external beam radiation demonstrably leads to better outcomes in breast cancer; well worth living in a Houston hotel for 6 weeks.... said no one ever. Except... Tom Buchholz. Evidence given: he's a lousy golfer.
The sad part is these people actually believe it.
The right way, the wrong way, and the MD Anderson way.
All MDA attendings have fallen in line with the company now, not just Buchholz. Every one of my patients is told erroneously that I "won't be able to spare your heart" or I'm "just a general radonc so won't be able to treat their sarcoma the way they could." It's absolutely infuriating that these academic attendings come up with all these bull**** hoops for us to jump through to be board certified, being ACRO accredited, etc, but then throw us all under the bus at every opportunity. Don't even get me started on the Alliance of Dedicated Cancer Centers (ADCC, http://www.adcc.org/). They take completely worthless SEER data with no cofounding variables whatsoever, then claim their survival is higher than the rest of us, even though in my experience only the wealthy and aggressively interested in care have the resources available to bother to travel to these places for treatment. They also erroneously claim their care is cheaper than the rest of us, which is so wrong it's laughable.
Guess the academic elites should have considered what flooding the field with grads would eventually do to the markets in their backyard....I think it's hilarious that MDACC claims to have better equipment than the rest of us when Varian and Elekta are the manufacturers of all of our equipment. I let patients know that and then they understand that they don't need to go the distance to get the same care (whose contours are done by a resident instead of an attending).
All MDA attendings have fallen in line with the company now, not just Buchholz. Every one of my patients is told erroneously that I "won't be able to spare your heart" or I'm "just a general radonc so won't be able to treat their sarcoma the way they could." It's absolutely infuriating that these academic attendings come up with all these bull**** hoops for us to jump through to be board certified, being ACRO accredited, etc, but then throw us all under the bus at every opportunity. Don't even get me started on the Alliance of Dedicated Cancer Centers (ADCC, http://www.adcc.org/). They take completely worthless SEER data with no cofounding variables whatsoever, then claim their survival is higher than the rest of us, even though in my experience only the wealthy and aggressively interested in care have the resources available to bother to travel to these places for treatment. They also erroneously claim their care is cheaper than the rest of us, which is so wrong it's laughable.
Very true regarding the ADCC. The GAO (government accountability organization) did a study on this in 2015, with not surprising findings...
http://www.gao.gov/products/GAO-15-199
Surprise, surprise, they are arguing for payment parity, something that should be happening between hospital-based and freestanding radiation oncology.
It all comes down to who has the best lobbyists
Docs will eat each other for a relatively bigger piece of the ever-shrinking pie. Meanwhile, nary any attention is paid the fundamental problem of the ever-shrinking pie.
Divide and conquer has worked well on medical school grads.
Looks like cutting back on holiday parties wasn't enough...
https://www.google.com/amp/www.wsj....ughly-5-of-workforce-1483654693?client=safari
I like how the president's salary is over 2 mil, yet he was also approved to receive a bonus of around 200k.
“I could have done a better job administratively, a better job listening, a better job communicating,” the statement said. “Forgive me for my short comings. I regret them, but I was, and continue, to be committed to saving lives and reduce suffering, to help MD Anderson accelerate the march towards prevention and cure, particularly for the underserved.”
DePinho had been in the top job for five and a half years and had been under a particular spotlight in the past two years, as the hospital’s financial situation deteriorated.
MD Anderson, which is known for pioneering cancer research as well as clinical care, posted a $267 million loss in the 2016 fiscal year and was expecting to lose as much as $450 million2 in 2017, though it brings in about $4 billion in annual revenue. In January, DePinho announced nearly 1,000 layoffs, fueling deeper questions about his spending and management.
The president just announced his resignation.
https://www.statnews.com/2017/03/08/md-anderson-depinho-resigns/
DePinho out, Steve Hahn on the way up https://www.mdanderson.org/newsroom...joins-md-anderson-senior-leadership-team.html
Sent from my iPhone using SDN mobile app
Check out the package DePinho gets now...
Recently resigned MD Anderson president takes $1M+ salary package as professor
Sounds like par for the course in the corporate world... do a terrible job, get w golden parachuteCheck out the package DePinho gets now...
Recently resigned MD Anderson president takes $1M+ salary package as professor
Looks like MD Anderson is doing just fine: MD Anderson posts four months of positive operating margins as deficit shrinks to $43.9 million – The Cancer Letter Publications
The initial loss was largely attributed to the Epic transition. Improper billing, decrease in clinical volume (due to the transition and inability to effectively manage work flow) are some of the major contributions. Obviously there were other factors too, but it seems like a majority of the executive board has been ousted and slowly being replaced. Interim chair is a radiation oncologist.